Silibinin and Ellagic Acid Increase the Expression of Insulin Receptor Substrate 1 Protein in Ultraviolet Irradiated Rat Skin

dc.contributor.author Gorgisen, G.
dc.contributor.author Ozkol, H.
dc.contributor.author Tuluce, Y.
dc.contributor.author Arslan, A.
dc.contributor.author Ecer, Y.
dc.contributor.author Keskin, S.
dc.contributor.author Ragbetli, M. C.
dc.date.accessioned 2025-05-10T17:04:34Z
dc.date.available 2025-05-10T17:04:34Z
dc.date.issued 2020
dc.description Tuluce, Yasin/0000-0002-7312-5934; Kaya, Zehra/0000-0001-6222-7882; Keskin, Seda/0000-0002-4726-982X; Ragbetli, Murat Cetin/0000-0002-8189-264X en_US
dc.description.abstract Daily exposure to ultraviolet (UV) light induces inflammation and tumorigenesis in the skin. Silibinin and ellagic acid are natural products that exhibit anti-inflammatory and anti-tumorigenic properties. Insulin receptor substrate protein 1 (IRS1) is important for skin homeostasis and physiology, but its activity following UV radiation remains unclear. We investigated the effects of ellagic acid and silibinin on IRS1 expression in ultraviolet A (UVA) and ultraviolet B (UVB) irradiated rat skin. Forty-two female Wistar rats were divided randomly into six groups of seven animals. The dorsal skin of rats was exposed to UVA + UVB, then treated with ellagic acid and silibinin by gavage. IRS1 expression in skin tissues was determined by western blot analysis. IRS1 expression increased significantly following treatment with ellagic acid and silibinin in UVA + UVB irradiated skin compared to the UVA + UVB only group. After UVA + UVB treatment, ellagic acid effected greater induction of IRS1 expression than silibinin. Our findings suggest that the photoprotective roles of ellagic acid and silibinin may be due to induction of IRS1 expression in UVA + UVB treated rat skin. en_US
dc.identifier.doi 10.1080/10520295.2020.1753238
dc.identifier.issn 1052-0295
dc.identifier.issn 1473-7760
dc.identifier.scopus 2-s2.0-85084265648
dc.identifier.uri https://doi.org/10.1080/10520295.2020.1753238
dc.identifier.uri https://hdl.handle.net/20.500.14720/6052
dc.language.iso en en_US
dc.publisher Taylor & Francis Ltd en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Ellagic Acid en_US
dc.subject Insulin Receptor en_US
dc.subject Irs1 en_US
dc.subject Rat en_US
dc.subject Silibinin en_US
dc.subject Skin en_US
dc.subject Ultraviolet A en_US
dc.subject Ultraviolet B en_US
dc.title Silibinin and Ellagic Acid Increase the Expression of Insulin Receptor Substrate 1 Protein in Ultraviolet Irradiated Rat Skin en_US
dc.type Article en_US
dspace.entity.type Publication
gdc.author.id Tuluce, Yasin/0000-0002-7312-5934
gdc.author.id Kaya, Zehra/0000-0001-6222-7882
gdc.author.id Keskin, Seda/0000-0002-4726-982X
gdc.author.id Ragbetli, Murat Cetin/0000-0002-8189-264X
gdc.author.scopusid 55910152400
gdc.author.scopusid 36574004100
gdc.author.scopusid 10143414500
gdc.author.scopusid 57216674261
gdc.author.scopusid 57216672733
gdc.author.scopusid 22635043900
gdc.author.scopusid 55876457500
gdc.author.wosid Arslan, Ayse/Mah-2595-2025
gdc.author.wosid Keskin, Seda/A-4616-2019
gdc.author.wosid Kaya, Zehra/Hsg-7209-2023
gdc.author.wosid Rağbetli, Murat/Abg-5631-2021
gdc.author.wosid Tuluce, Yasin/S-6812-2016
gdc.author.wosid Ragbetli, Murat Cetin/Q-5060-2017
gdc.coar.access metadata only access
gdc.coar.type text::journal::journal article
gdc.description.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
gdc.description.departmenttemp [Gorgisen, G.; Ozkol, H.; Tuluce, Y.; Arslan, A.; Ecer, Y.; Kaya, Z.] Van Yuzuncu Yil Univ, Dept Med Biol, Sch Med, Van, Turkey; [Keskin, S.; Ragbetli, M. C.] Van Yuzuncu Yil Univ, Dept Med Histol & Embryol, Sch Med, Van, Turkey en_US
gdc.description.endpage 646 en_US
gdc.description.issue 8 en_US
gdc.description.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
gdc.description.scopusquality Q3
gdc.description.startpage 641 en_US
gdc.description.volume 95 en_US
gdc.description.woscitationindex Science Citation Index Expanded
gdc.description.wosquality Q4
gdc.identifier.pmid 32347127
gdc.identifier.wos WOS:000532040700001
gdc.index.type WoS
gdc.index.type Scopus
gdc.index.type PubMed

Files